©The Author(s) 2026.
World J Clin Cases. Feb 26, 2026; 14(6): 118263
Published online Feb 26, 2026. doi: 10.12998/wjcc.v14.i6.118263
Published online Feb 26, 2026. doi: 10.12998/wjcc.v14.i6.118263
Table 1 Domains of diagnostic uncertainty in endophthalmitis
| Domain | Key sources of uncertainty | Clinical implications |
| Clinical | (1) Overlap in presenting features between infective and non-infective intraocular inflammation; (2) Variable severity at presentation (early, indolent, or partially treated infections); (3) Atypical presentations in immunocompromised or elderly patients; and (4) Rapid inflammatory responses in toxic or immune-mediated conditions mimicking infection | (1) Clinical severity alone cannot reliably distinguish infection from sterile inflammation; (2) Risk of delayed treatment in true infection or overtreatment in non-infective cases; and (3) Necessitates probabilistic decision-making rather than binary diagnosis |
| Microbiological | (1) High rates of culture negativity despite clinically presumed infection; (2) Prior antibiotic exposure reducing yield; (3) Fastidious or low-virulence organisms; (4) PCR positivity without viable organisms; and (5) Unclear significance of low microbial DNA copy numbers | (1) Absence of culture growth does not exclude infection; (2) PCR results require cautious interpretation and clinical correlation; and (3) Microbiological data often lag behind therapeutic decision-making |
| Imaging | (1) B-scan ultrasonography lacks specificity for infective vs sterile vitritis; (2) OCT findings reflect secondary inflammatory damage rather than etiology; (3) Widefield imaging documents extent but not cause of inflammation; and (4) Limited ability to predict microbial virulence or disease trajectory | (1) Imaging serves as an adjunct rather than a diagnostic arbiter; (2) Risk of over-interpreting nonspecific structural changes; and (3) Imaging cannot replace clinical and microbiological synthesis |
| Systemic/etiologic context | (1) Absence of identifiable ocular breach does not exclude infection; (2) Presence of a breach does not exclude toxic or immune-mediated reactions; (3) Subclinical or occult systemic infections; and (4) Masquerade syndromes (e.g., vitreoretinal lymphoma) | (1) Difficulty distinguishing endogenous infection from non-infective masquerade syndromes; (2) Requires parallel systemic evaluation and longitudinal reassessment; and (3) Misclassification may lead to inappropriate therapy or delayed diagnosis |
- Citation: Venkatesh R, Hande P, James E, Chokkahalli NK, Ranganath P, Kathare R, Prabhu V, Jayadev C, Tendulkar K, Raj P, Malwe G, Tripathi S, Biradar P, Sirsikar A, Yadav NK. Areas of uncertainty in endophthalmitis care. World J Clin Cases 2026; 14(6): 118263
- URL: https://www.wjgnet.com/2307-8960/full/v14/i6/118263.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i6.118263